China SXT Pharmaceuticals Inc.

SXTC | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.93

-$0.05 (-1.68%)

At close: Nov 5, 2026, 4:00 PM ET

$2.86

-$0.07 (-2.39%)

After-hours: Nov 5, 2026, 7:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2026 Mar 31, 2026	FY 2025 Mar 31, 2025	FY 2024 Mar 31, 2024	FY 2023 Mar 31, 2023	FY 2022 Mar 31, 2022	FY 2021 Mar 31, 2021
Net Income	-6.21M	-3.3M	-3.1M	-5.93M	-5.74M	-2.75M
Depreciation & Amortization	143.22K	82.3K	203.25K	250.16K	320.01K	345.41K
Stock-Based Compensation	n/a	n/a	352.1K	554.57K	n/a	n/a
Other Working Capital	133.43K	-362.56K	159.41K	83.91K	826.26K	-506.08K
Other Non-Cash Items	4.43M	1.85M	996.69K	408.69K	1.12M	2.89M
Deferred Income Tax	n/a	n/a	n/a	3.23M	n/a	-192.68K
Change in Working Capital	-2.39M	-971.74K	-381.56K	1.42M	1.92M	-1.61M
Operating Cash Flow	-4.02M	-2.35M	-1.93M	-80.76K	-2.37M	-1.32M
Capital Expenditures	-4	-2.02K	-7.06K	-70.68K	-62.49K	-93.04K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-8.85M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	65.54K	33.49K	58.38K	15.58K	3.13M
Investing Cash Flow	-1.25M	63.52K	26.42K	-12.3K	-46.91K	-5.81M
Debt Repayment	144.16K	-65.12K	1.31M	4M	n/a	-124.95K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	5.7M	-3.93M	-3.26M	1.63M	12.53M
Financial Cash Flow	14.43M	8.4M	-2.62M	2.94M	1.63M	12.41M
Net Cash Flow	10.05M	6.05M	-5.29M	1.8M	-399.13K	6.07M
Free Cash Flow	-4.02M	-2.35M	-1.94M	-151.44K	-2.44M	-1.41M
Adj. Free Cash Flow	-4.02M	-2.35M	-2.29M	-706.01K	-2.44M	-1.41M
Maintenance CapEx	-4	-2.02K	-7.06K	-70.68K	-62.49K	-93.04K
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-4.02M	-2.35M	-1.94M	-151.44K	-2.44M	-1.41M